Integrating Proteomic and Functional Genomic Technologies in Discovery-driven Translational Breast Cancer Research
Authors:
- Julio E. CelisJCJulio E. Celis
- Pavel GromovPGPavel Gromov
- Irina GromovaIGIrina Gromova
- José M. A. MoreiraJosé M. A. Moreira
- Teresa CabezónTCTeresa Cabezón
- Noona AmbartsumianNANoona Ambartsumian
- Mariam GrigorianMGMariam Grigorian
- Eugene LukanidinELEugene Lukanidin
- Per Thor StratenPSPer Thor Straten
- Per GuldbergPGPer Guldberg
- Jirina BartkovaJBJirina Bartkova
- Jiri BartekJBJiri Bartek
Open Access
- 1 June 2003
- journal article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 2 (6) , 369-377
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast CancerJournal of Clinical Oncology, 2003
- Reporting of performance indicators of mammography screening in EuropeEuropean Journal Of Cancer Prevention, 2003
- DNA microarrays in breast cancer: the promise of personalised medicineThe Lancet, 2003
- Gene expression profiles of human breast cancer progressionProceedings of the National Academy of Sciences, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Molecular and Biologic Markers of Premalignant Lesions of Human BreastAdvances in Anatomic Pathology, 2002
- Long-term effects of mammography screening: updated overview of the Swedish randomised trialsThe Lancet, 2002
- Global cancer statistics in the year 2000The Lancet Oncology, 2001
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998